Quest Diagnostics Sees Fiscal 2024 Revenues Of $9.35B-$9.45B And Adjusted EPS Of $8.60-$8.90, Compared To Consensus Of $9.38B And $8.97, Respectively
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics forecasts its fiscal 2024 revenues to be between $9.35B and $9.45B with an adjusted EPS of $8.60 to $8.90, slightly below the consensus expectations of $9.38B in revenue and $8.97 in EPS.
February 01, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Quest Diagnostics forecasts fiscal 2024 revenues and EPS slightly below consensus estimates, indicating potential cautious investor sentiment.
Quest Diagnostics' projected fiscal 2024 revenues and EPS are slightly below the consensus estimates, which could lead to cautious or negative investor sentiment in the short term. This forecast might be interpreted as a sign of potential challenges or conservative expectations by the company, affecting stock price negatively.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100